Shares of Exact Sciences Corp. jumped after Abbott Laboratories announced a deal to acquire the cancer screening test maker ...

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, ...

Gilead Sciences, Inc. is rated a Buy with robust profitability, solid dividend, prudent M&A and 15-20% upside potential. Read ...

SHELTON, CONNECTICUT / ACCESS Newswire / November 17, 2025 / NanoViricides, Inc. (NYSE Amer.:NNVC) (the “Company”), reports that it has filed its Quarterly Report on Form 10-Q for the fiscal quarter ...

OS Animal Health may soon stand on its own. A subsidiary of OS Therapeutics—a company known for Listeria -based oncology ...

Founded in 2012, Genuine Biotech focuses on the development and production of innovative drugs for viral infections, oncology ...

Shares of Ligand Pharmaceuticals are absolutely flying as investors line up behind the company's unique royalty-based ...

News of an apparently impending sale to a strategic investor sent shares of Exact Sciences ( EXAS +23.68%) skyward on ...

Learn more about whether Aurinia Pharmaceuticals Inc. or Merus N.V. is a better investment based on AAII's A+ Investor grades ...

Olema Pharmaceuticals (OLMA) surges after Roche's breast cancer data, but caution is urged as key clinical results are ...

Though healthcare stocks have been much more measured this year, there are bright spots there as well. The medical-device maker Medtronic (MDT) closed at its highest price since May 12, 2022, after ...

Olema OLMA stock fell 7% after-hours following announcement of a public offering of common stock and pre-funded warrants ...